Similar Papers

Paper Title
Journal
Date
Author
PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?
U.A Matulonis ... B.J Monk
Annals of Oncology | VOL. 28
U.A Matulonis, et. al.U.A Matulonis ... B.J Monk
01 Mar 2017
RANKL Up-regulates Brain-type Creatine Kinase via Poly(ADP-ribose) Polymerase-1 during Osteoclastogenesis
Jianfeng Chen ... Yabing Chen
Journal of Biological Chemistry | VOL. 285
Jianfeng Chen, et. al.Jianfeng Chen ... Yabing Chen
01 Nov 2010
KIF4 Motor Regulates Activity-Dependent Neuronal Survival by Suppressing PARP-1 Enzymatic Activity
Ryosuke Midorikawa ... Nobutaka Hirokawa
Cell | VOL. 125
Ryosuke Midorikawa, et. al.Ryosuke Midorikawa ... Nobutaka Hirokawa
01 Apr 2006
Inhibition of Caspase-3-mediated Poly(ADP-ribose) Polymerase (PARP) Apoptotic Cleavage by Human PARP Autoantibodies and Effect on Cells Undergoing Apoptosis
Patrice Decker ... Sylviane Muller
Journal of Biological Chemistry | VOL. 275
Patrice Decker, et. al.Patrice Decker ... Sylviane Muller
01 Mar 2000
View more papers

More From: Immunology Today

Paper Title
Journal
Date
Author
Do glucocorticoids participate in thymocyte development?
Jonathan D Ashwell ... Jérôme Galon
Immunology Today | VOL. 21
Jonathan D Ashwell, et. al.Jonathan D Ashwell ... Jérôme Galon
01 Dec 2000
Helicobacter pylori vaccine strategies – triggering a gut reaction
W.John W Morrow ... Brendan W Wren
Immunology Today | VOL. 21
W.John W Morrow, et. al.W.John W Morrow ... Brendan W Wren
01 Dec 2000
Natural antibodies and complement link innate and acquired immunity
Adrian F Ochsenbein ... Rolf M Zinkernagel
Immunology Today | VOL. 21
Adrian F Ochsenbein, et. al.Adrian F Ochsenbein ... Rolf M Zinkernagel
01 Dec 2000
Stress-free T-cell development: glucocorticoids are not obligatory
Dale I Godfrey ... Timothy J Cole
Immunology Today | VOL. 21
Dale I Godfrey, et. al.Dale I Godfrey ... Timothy J Cole
01 Dec 2000
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.